EyePoint Pharmaceuticals
(NASDAQ:EYPT)
$12.09
-0.58[-4.58%]
At close: May 10
$12.09
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Wed May 8th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

EyePoint Pharmaceuticals Stock (NASDAQ:EYPT), Quotes and News Summary

EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.

Open$12.800
Close$12.090
Volume / Avg.1.070M / 1.164M
Day Range11.970 - 12.900
52 Wk Range5.670 - 30.990
Market Cap$629.697M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
32
Short Interest
14.78%
Days to Cover11.63

Recent News

Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
Avi Kapoor
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
3
Dec 23
2
Jan
1
Feb
1
Mar
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EYPT
THRD

FAQ

Q

How do I buy EyePoint Pharmaceuticals (EYPT) stock?

A

You can purchase shares of EyePoint Pharmaceuticals (NASDAQ: EYPT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are EyePoint Pharmaceuticals's (EYPT) competitors?

A

Other companies in EyePoint Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Verona Pharma (NASDAQ:VRNA).

Q

What is the target price for EyePoint Pharmaceuticals (EYPT) stock?

A

The latest price target for EyePoint Pharmaceuticals (NASDAQ: EYPT) was reported by Baird on Wednesday, May 8, 2024. The analyst firm set a price target for 38.00 expecting EYPT to rise to within 12 months (a possible 214.31% upside). 24 analyst firms have reported ratings in the last year.

Q

Current Stock Price for EyePoint Pharmaceuticals (EYPT)?

A

The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $12.09 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does EyePoint Pharmaceuticals (EYPT) pay a dividend?

A

There are no upcoming dividends for EyePoint Pharmaceuticals.

Q

When is EyePoint Pharmaceuticals (NASDAQ:EYPT) reporting earnings?

A

EyePoint Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Q

Is EyePoint Pharmaceuticals (EYPT) going to split?

A

There is no upcoming split for EyePoint Pharmaceuticals.

Q

What sector and industry does EyePoint Pharmaceuticals (EYPT) operate in?

A

EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch